TherapeuticsMD Inc logo

TXMD

Materials

TherapeuticsMD Inc

$2.03-0.04 (-1.93%)LIVE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving TXMD Today?

No stock-specific AI insight has been generated for TXMD yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$23M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—

Trading

Volume24K
Avg Volume (10D)—
Shares Outstanding11.6M

Price Data

Open$2.02
Previous Close$2.07
Day High$2.07
Day Low$1.99
52 Week High—
52 Week Low—

About TherapeuticsMD Inc

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

therapeuticsmd.com
1 employees
Listed January 28, 2002
MaterialsPHARMACEUTICAL PREPARATIONS

Company Details

Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SICPHARMACEUTICAL PREPARATIONS
CIK—
Composite FIGI—
Share Class FIGI—